Assoc. Prof. Dr. Nguyen Dinh Hoa – Deputy Director of the Institute for Regenerative Medicine and Stem Cells has just proposed to buy 20 million shares of HHV.

• 

Assoc. Prof. Dr. Nguyen Dinh Hoa – Deputy Director of the Institute of Regenerative Medicine and Stem Cells has just proposed to buy 20 million shares of HHV. Photo: Quang Toan/BNEWS/VNA

Deo Ca Transport Infrastructure Investment Joint Stock Company (UPCoM: HHV) has just informed that Assoc. Prof. Dr. Nguyen Dinh Hoa has just proposed to buy 20 million shares of HHV.

Accordingly, Assoc. Prof. Dr. Nguyen Dinh Hoa confirmed that he and some experts in the field of regenerative medicine have submitted a proposal to HHV leaders to buy 20 million shares of HHV and commits to keep for the next 5 years through HMG Holding Group which owns Medicshare Medical Services Company and Regenmedic Biotechnology Company with an international network around the world and Vietnam in over 10 years.

 “I am a shareholder of HHV. Recently, I attended the 2021 Extraordinary General Meeting of Shareholders of HHV. Here, I see that this company’s development strategy is in line with our investment plan”, Assoc. Prof. Dr. Nguyen Dinh Hoa said.

Specifically, in the development strategy of HHV, the development of infrastructure is parallel with the development of services to serve social life and improve people’s living standards, including the development of high-tech healthcare. Assoc. Prof. Dr. Nguyen Dinh Hoa said that this model is currently popular in developed countries.

“The development strategy of HHV contributes to the safety of Vietnamese people. Aiming to social security will have two advantages, the first is to benefit the people because they will be better served. The second is to bring benefits to the shareholders of HHV”, said Assoc. Prof. Dr. Hoa.

Assoc. Prof. Dr. Nguyen Dinh Hoa is an expert in spine surgery and application of regenerative medicine in the treatment of orthopedic and spine injuries. He has a research network with centers throughout the US, Japan, Korea… Currently Assoc. Prof. Dr. Nguyen Dinh Hoa builds an ecosystem of Specialist clinics – Medical centers – Specialized hospitals with the core of application high technology in diagnosis and treatment.

In the recently published report of the third quarter of 2021, despite many difficulties due to the epidemic, HHV still achieved positive business results. Revenue in the third quarter of 2021 increased by 53%, reaching VND 452 billion. On the other hand, the strong increase in financial revenue from dividends, distributed profits, and significant reduction in expenses helped the company has a profit after tax of more than VND 83 billion, 2.6 times higher than the same period last year.

On November 1, Deo Ca Transport Infrastructure Investment Joint Stock Company (UpCOM: HHV) held 2021 Extraordinary General Meeting of Shareholders. Photo: HHV

Recently, HHV decided to increase charter capital to VND 5,347 billion in 2022, double the current amount. In addition, the company also raised its 2021 revenue plan to 2,000 billion dong and after-tax profit to 283 billion dong, up 65% and 76% respectively compared to the original plan.

On the stock market, HHV shares are trading around VND 21,000/share (the morning session of November 8). Although this stock code has not had a breakthrough in market price, it has been noticed by many investors because of its sudden increase in liquidity recently, creating projects that bring real value to society.

Especially, during the outbreak of COVID-19 in October, Deo Ca Transport Infrastructure Investment Joint Stock Company “opened” Hai Van tunnel to serve more than 20,000 people from epidemic provinces to their hometown safely./.

Source: https://bnews.vn/bat-ngo-mot-co-dong-de-nghi-mua-toi-20-trieu-co-phieu-hhv/220218.html